Physician profile
Robert B Wallace
NPI 1598792293
$914.84
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $136 · 2021: $26.56 · 2022: $124 · 2023: $154 · 2024: $163 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $206.06 | 2019-2024 | Lensx, Argos |
| Johnson & Johnson Surgical Vision, INC. | $166.51 | 2023-2025 | Tecnis Simplicity, Veritas Vision System, Tecnis Iol |
| Optovue, INC. | $136.33 | 2020 | |
| Novartis Pharmaceuticals Corporation | $115.74 | 2021-2023 | |
| Glaukos Corporation | $92.09 | 2024-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Biotissue Holdings INC. | $53.03 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $40.54 | 2022 | |
| Medtronic, INC. | $35.49 | 2023 | Aquamantys(Tm) |
| Ani Pharmaceuticals, INC. | $25.72 | 2024 | Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.55 | 2019 | |
| Allergan, INC. | $13.56 | 2021 | |
| Amgen INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.